A New Era of Early-Stage Cancer Care: Clinical Impact of Pathologic Response to Immunotherapy

Watch an on-demand webcast and download slides from a live symposium covering the latest on pathologic response to neoadjuvant immunotherapy in multiple solid tumors.

Share

Program Content

Activities

Path Response With CT and IO
Current State of Pathologic Response in the Neoadjuvant Setting: Pathologic Response With Chemotherapy and Immunotherapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2023

View Activity
Path Response to IO: Clin Evidence
Clinical Evidence Using Pathologic Response as Clinical Trial Endpoint
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2023

View Activity

Activities

Impact of Path Response to IO
A New Era of Early-Stage Cancer Care: Clinical Impact of Pathologic Response to Immunotherapy
Video
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2023

Expires: May 02, 2024

View Activity

Faculty

cover img faculity

Patrick Forde, MBBCh

Director, Thoracic Oncology Research Program
Oncology Department
Johns Hopkins University
Baltimore, Maryland

cover img faculity

Michael T. Tetzlaff, MD, PhD

Professor of Pathology
Division of Dermatopathology
University of California at San Francisco
San Francisco, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb